Parker Institute for Cancer Immunotherapy

67 employees

Parker Institute for Cancer Immunotherapy coordinates cancer research efforts between scientists, clinicians and partners in the industry.

Investor insights

Sectors invested in

Biotechnology10

Health Care8

Therapeutics7

Medical3

Manufacturing3

Genetics3

cancer3

Immuno-oncology and Re-programming the Tumor Microenvironment2

cell therapy2

technology2

artificial intelligence2

immunology2

Life Science2

Cloud Computing2

machine learning2

CD81

Immunology1

Immunocology1

Personalized medicine1

Biomarker1

Funding rounds participated in

$43M sweet spot round size

Most of their 10 investments are in rounds between $30M and $100M

Basic info

Industry

research services

Sectors

Personal Health

Health Care

Therapeutics

Date founded

2016

Investments made

Psioxus Therapeutics raised $30M on January 5, 2023

Investors: Westlake Village BioPartners®, ARCH Venture Partners and Parker Institute for Cancer Immunotherapy

Psioxus Therapeutics raised $30M on January 5, 2023

Investors: Westlake Village BioPartners®, ARCH Venture Partners and Parker Institute for Cancer Immunotherapy

ArsenalBio raised $221M on September 6, 2022

Investors: Kleiner Perkins, SoftBank Investment Advisers, Hitachi Ventures, UCSF, Sixth Street, Westlake Village BioPartners® and Parker Institute for Cancer Immunotherapy

Senti Biosciences raised $51M on June 9, 2022

Investors: T. Rowe Price, Leaps by Bayer, The Invus Group, Pear VC, 8VC and Parker Institute for Cancer Immunotherapy

Affini-T Therapeutics raised $175M on March 22, 2022

Investors: Humboldt Fund, Vida Ventures, LLC, Leaps by Bayer, fred hutch, Agent Capital, Catalio Capital Management, - and Parker Institute for Cancer Immunotherapy

ArsenalBio raised $85M on October 17, 2019

Investors: UCSF Foundation Investment Company, Westlake Village BioPartners®, Osage University Partners (OUP), University of California, Kleiner Perkins and Parker Institute for Cancer Immunotherapy

Tmunity Therapeutics Incorporated raised $35M on April 19, 2018

Investors: Lilly Asia Ventures, Gilead Sciences, PingAn Ventures, University of Pennsylvania, Kleiner Perkins, Be The Match BioTherapies and Parker Institute for Cancer Immunotherapy

Tmunity Therapeutics Incorporated raised $100M on January 23, 2018

Investors: Lilly Asia Ventures, Gilead Sciences, University of Pennsylvania, PingAn Ventures, Be The Match BioTherapies and Parker Institute for Cancer Immunotherapy

ImaginAb raised $8M on September 14, 2017

Investors: Adage Capital Management, Nextech Invest and Parker Institute for Cancer Immunotherapy

Tmunity Therapeutics Incorporated raised $10M on December 9, 2015

Investors: Parker Institute for Cancer Immunotherapy